Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llac078 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Maddalena Napolitano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
- Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II.
- Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
- Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
ORCID-Profile: Luca Potestio
Zitieren
APA
Napolitano, M., Potestio, L., Hansel, K., Marietti, R., Piscitelli, I., Fabbrocini, G., Stingeni, L., & Patruno, C. (2023). Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llac078
Vancouver
Napolitano M, Potestio L, Hansel K, Marietti R, Piscitelli I, Fabbrocini G, et al. Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llac078
BibTeX
@article{Napolitano2023,
author = {Napolitano, Maddalena and Potestio, Luca and Hansel, Katharina and Marietti, Rossella and Piscitelli, Ilaria and Fabbrocini, Gabriella and Stingeni, Luca and Patruno, Cataldo},
title = {Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llac078}
}
EUVIMED